Simpson et al., 1997 - Google Patents
Characterization of the adaptor-related protein complex, AP-3Simpson et al., 1997
View HTML- Document ID
- 734040906483488661
- Author
- Simpson F
- Peden A
- Christopoulou L
- Robinson M
- Publication year
- Publication venue
- The Journal of cell biology
External Links
Snippet
We have recently shown that two proteins related to two of the adaptor subunits of clathrincoated vesicles, p47 (μ3) and β-NAP (β3B), are part of an adaptor-like complex not associated with clathrin (Simpson, F., NA Bright, MA West, LS Newman, RB Darnell, and MS …
- 102000004169 proteins and genes 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Simpson et al. | Characterization of the adaptor-related protein complex, AP-3 | |
Peden et al. | Assembly and function of AP-3 complexes in cells expressing mutant subunits | |
Blott et al. | Fas ligand is targeted to secretory lysosomes via a proline-rich domain in its cytoplasmic tail | |
De Angelis et al. | Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression | |
Wasmeier et al. | Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes | |
Kamiguchi et al. | A neuronal form of the cell adhesion molecule L1 contains a tyrosine-based signal required for sorting to the axonal growth cone | |
Ménager et al. | Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4 | |
Mizuno et al. | STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif | |
Roselli et al. | Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations | |
Mullock et al. | Syntaxin 7 is localized to late endosome compartments, associates with Vamp 8, and is required for late endosome–lysosome fusion | |
Page et al. | γ-Synergin: an EH domain–containing protein that interacts with γ-adaptin | |
Huan et al. | Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins | |
Lavezzari et al. | Subunit-specific regulation of NMDA receptor endocytosis | |
Sheikh et al. | Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor | |
Funami et al. | The cytoplasmic ‘linker region’in Toll-like receptor 3 controls receptor localization and signaling | |
Howard et al. | CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins | |
Hashiramoto et al. | Characterization of insulin-responsive GLUT4 storage vesicles isolated from 3T3-L1 adipocytes | |
Mariner et al. | ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120ctn in E-cadherin complexes | |
Jablonka et al. | Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy | |
Parsons et al. | Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind α5 chain-containing human laminin with high affinity | |
Falivelli et al. | Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation | |
Bradney et al. | Regulation of E2A activities by histone acetyltransferases in B lymphocyte development | |
Singer-Krüger et al. | Yeast Ypt51p and mammalian Rab5: counterparts with similar function in the early endocytic pathway | |
Tao | Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects | |
Nag et al. | Rab4A organizes endosomal domains for sorting cargo to lysosome-related organelles |